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Abstract—This research focuses on modeling the diffusion
process that occurs in the human body when an analgesic
drug is taken up, by using fractional-order impedance models
(FOIMs). We discuss the measurement of a suitable feedback
signal that can be used in a model-based control strategy. With
this knowledge an early dawn concept of a pain sensor is
presented. The major challenges that are encountered during
this development consist of identification of the patient model,
validation of the pain sensor and validation of the effect of the
analgesic drug.
Index Terms—Analgesia, pain relief level, non-invasive pain
sensor, model-based predictive control (MPC), fractional-order
impedance model (FOIM)
I. INTRODUCTION
The last few decades, modern medicine has success-
fully been influenced by advanced control technologies
resulting in applications such as robotic surgery, electro-
physiological system life support and image-guided therapy
and surgery [1]. An interesting application of control in
medicine is clinical pharmacology and in particular the
control of general anesthesia during surgery and in the
intensive care unit (ICU). Monitoring and controlling the
depth of anesthesia for surgical patients poses interesting
challenges to the control engineer [2] as it is a multi-
variable interaction process that has captured the attention of
engineers and clinicians already decades ago [3]. The first
designs were expert systems that advised the anesthesiologist
upon optimal drug infusion rates during clinical trials [4].
Control of anesthesia has a manifold of challenges, with
multi-variable characteristics, different dynamics depending
on anesthetic substances and stability problems [5].
General anesthesia, where the patient is completely un-
conscious, has the aim of ensuring sleep, amnesia, loss
of pain, relaxation of skeletal muscles and loss of control
of reflexes of the autonomic nervous system. It consists
of three components acting simultaneously on the patient’s
vital signs: hypnosis (ensuring sleep and amnesia), analgesia
(ensures loss of pain) and neuromuscular blockade (relaxes
the skeletal muscles and the motor reflexes). Hypnosis is
relatively well-characterized and is in standard clinical prac-
tice monitored by sensors based on electroencephalogram
(EEG) data. Neuromuscular blockade immobilizes the pa-
tient during surgical procedures or intensive care and is also
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a relatively well-characterized process with standard sensors,
such as motion sensors, available. By contrast, analgesia is
far from being well-characterized and no sensor is available
for measuring the pain relief levels that a patient experiences
during general anesthesia.
The advantage of automated closed loop control of anes-
thesia is that it gives a continuous drug delivery, contrary
to intermittent control which is nowadays standard practice.
A continuous drug delivery ensures that there is no under-
or over-dose of hypnotic or analgesic drugs that could result
in patients that feel pain during surgery but are unable to
move. Erroneous feedback information, biased either by the
presence of artifacts (e.g. eye movement, leg movement,
coughing, sneezing, choking, shivering) either by patient
model mismatch, is one of the major problems for the
control algorithms [6]. As result the quality of the measured
signals decreases, leading to the need of complex numerical
filtering techniques. The latter require longer computation
times, hence introducing artificial time delays which vary
from one time instant to another, dependent on the signal
quality. If not dealt-with appropriately, such varying time-
delays are a source of poor feedback control. Advanced
control techniques such as model-based predictive control
(MPC) can deal successfully with these variable time delays,
nonlinearities, input and output constraints [7].
The research presented in this paper merges classical
control theory with the young promising field of fractional-
order modeling to measure pain relief levels in an uncon-
scious patient and initiate the development of a biosensor
for analgesia levels. Few pioneering attempts to measure the
analgesic component of general anesthesia have shown that
current state-of-art is unable to deliver suitable signals and
models for optimal regulation. The result is then a high risk
of drug over- or under-dosing and unwanted post-operatively
effects, leading to increased hospitalization and health-care
costs for both society and patient [8]. We propose to employ
a mathematical tool called fractional-order impedance model
(FOIM) to model the pharmacological diffusion process that
takes place when the human body takes up an analgesic drug
such as remifentanil. These models can be used in a MPC
context to control the depth of analgesia in the unconscious
patient.
The paper is structured as follows: in section II, we
describe analgesia and the coinciding diffusion process.
Section III discusses the control method that will be used
in combination with the proposed analgesia sensor and the
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transducer (electrochemical, optical, magnetic, etc.) converts
the bio-recognition event into a measurable signal, the signal
processing part converts the signal into a readable form.
B. A prediction model for MPC
MPC is a model-based control strategy. Standard models
include step response models, transfer function models and
linear state space models, however, these models do not
suffice in modeling the dynamics of the diffusion processes
that occur in the human body.
In the past many attempts to model the diffusion pro-
cess have been made. Fractional Order Impedance Models
(FOIMs) have been shown to well-characterize these diffu-
sion processes [15], which in essence take place ubiquitously
in our body. It is therefore natural to choose these tools in
detecting, understanding and characterizing the process of
pain reception at the level of nociceptors.
In medicine, the field of fractional-order calculus has
barely been explored. However, this research field promises
to serve a whole range of applications with a large impact
on the progress of science and welfare. The last decades
have shown an increased interest in the research community
to employ parametric model structures of fractional-order
for analyzing nonlinear biological systems. The concept
of fractional-order (FO) – or non-integer order – systems
refers to those dynamical systems whose model structure
contains arbitrary order derivatives and/or integrals [16]. The
fractional-order derivatives and integrals are tools of the
Fractional Calculus theory. The dynamical systems whose
model can be approximated in a natural way using FO
terms, exhibit specific features: viscoelasticity, diffusion and
fractal structure. From previous work [17], we know now
that the multiple scale adaptation of neurons is consistent
with fractional order differentiation, such that the neuron’s
firing rate is a fractional derivative of slowly varying stimulus
parameters [18]. The findings of scale-free fluctuations in
the activity of neurons and synapses have been used to
illustrate the existence of multiple time-scale dynamics in
neurons and synapses. Additionally, there has been shown
that phase-locking phenomena can be explained by the
presence of fractal electrical neuronal networks, which lead
to a fractional-order impedance model of the neural network
[19]. However, the theoretical concepts of fractals, chaos and
multi-scale analysis have not yet been employed in the field
of anesthesia, where the electrical activity of the brain is
altered by the effects of hypnotic (propofol) and analgesic
(remifentanil) drugs.
Another option to model the diffusion processes in the
human body is to use compartmental models in combination
with fractional-order derivatives [20]. Three compartments
are used in this diffusion model: blood, muscle and fat.
Principles of Fractional Calculus
The fractional calculus is a generalization of integration
and derivation to non-integer (fractional) order operators. At
first, we generalize the differential and integral operators into
one fundamental operator Dnt (n the order of the operation)
which is known as fractional calculus.
Several definitions of this operator have been proposed.
All of them generalize the standard differential–integral
operator in two main groups: (a) they become the standard
differential–integral operator of any order when n is an
integer; (b) the Laplace transform of the operator Dnt is s
n
(provided zero initial conditions), and hence the frequency
characteristic of this operator is (jω)n. The latter is very
appealing for the design of parametric modelling and control
algorithms by using specifications in the frequency domain.
A fundamental Dnt operator, a generalization of integral
and differential operators (differintegration operator), is in-
troduced as follows:
Dnt =


dn
dtn
, n > 0
1, n = 0∫ t
0
(dα)−n, n < 0

 (1)
where n is the fractional order and dα is a derivative
function. Since this paper will focus on the frequency-
domain approach for FO derivatives and integrals, we shall
not introduce the complex mathematics for time domain
analysis. The Laplace transform for integral and derivative
order n are, respectively:
L
{
D−nt f(t)
}
= s−nF (s) (2)
L {Dnt f(t)} = s
nF (s) (3)
where F (s) = L {f(t)} and s is the Laplace complex vari-
able. The Fourier transform can be obtained by replacing s
by jω in the Laplace transform and the equivalent frequency-
domain expressions are:
1
(jω)n
=
1
ωn
(
cos
npi
2
− j sin
npi
2
)
(4)
(jω)n = ωn
(
cos
npi
2
+ j sin
npi
2
)
(5)
Thus, the modulus and the argument of the FO terms are
given by:
Modulus(dB) = 20 log
∣∣(jω)∓n∣∣ = ∓20n log |ω| (6)
Phase(rad) = arg
(
(jω)∓n
)
= ∓n
pi
2
(7)
resulting in a straight line with a slope of ∓20n passing
through 0 dB for ω = 1 for the magnitude (dB vs. log-
frequency), respectively a horizontal line, thus independent
with frequency, with value ∓npi
2
for the phase (rad vs. log-
frequency). The respective sketches are given in figure 8.
Principles of Compartmental Fractional Derivative Models
In this section a two compartmental fractional derivative
model is discussed. The basic idea behind this model can be
used to model diffusion processes in the human body by a
multi-compartmental model.
The model is formulated so that the mass balance is
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Fig. 8. Sketch representation of the FO integral and derivator operators in
frequency domain, by means of the Bode plots (magnitude above and phase
bellow).
preserved. In figure 9, we see a conceptual schematic of a
model with two compartments. Assume that qi(t) = vici,
for i = 1, 2 denote the amount of a drug in a specific
compartment. Here ci is the concentration of a drug and vi is
the volume of the i-th compartment and Kij is the fractional
rate of transfer from compartment i to compartment j.
The first compartment represents the place where the
drug is applied i.e. muscle, subcutaneous tissue or digestive
tract. The second compartment represents the plasma or any
other region in the body where the kinetics of the drug are
uniform. Traditionally, the two compartments are described
by a system of differential equations of integer order.
dq1(t)
dt
= K21q2(t)−K12q1(t)−K01q1(t) (8)
dq2(t)
dt
= K12q1(t)−K21q2(t)−K02q2(t) (9)
Recently, the fractional-order models seem to better suit the
dynamics of biological systems than other integer models. A
simple model of a two-compartmental system is then given
by the following equations:
τn1−1
1 0
Dn1t q1(t) = −K12q1(t), (10)
τn2−1
2 0
Dn2t q2(t) = K12q1(t)−K02q2(t), (11)
where we assumed K01 = 0, K21 = 0 and with the initial
conditions q1(0) = dose, and q2(0) = 0. In these equations
τ1 and τ2 are time constants which represent the speed of
diffusion, while n1 and n2 represent a non-integer between
K12q1 
K21q2 
Muscle 
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Fig. 9. Conceptual schematic of a two-compartment model.
0 and 1 and characterize the type of diffusion (sub-, super-,
etc).
IV. GRAND CHALLENGES
Several grand challenges are encountered in the develop-
ment of the proposed analgesic biosensor. We discuss the
major challenges in the remainder of this section.
To be able to control the level of analgesia in the un-
conscious patient, we apply a MPC strategy. This strategy
needs a reliable model of the process that it needs to control.
In traditional, non-human, systems, this model identification
is done by sending excitation signals into the system and
analyzing the corresponding output signals of the open-loop
system. However, as we are dealing with patients, it is not
possible to apply here the same strategy. Output signals
to analyze are available only after the nurse administers
a certain amount of analgesic drug. As the nurse only
administers this drug after examination of the patient, this
is no longer an open-loop system and system identification
can be compromised by this.
Another difficulty in the model identification is the fact
that every person reacts differently to a certain amount or
combination of drugs. Therefore, every model differs for
every patient i.e. inter-patient variability.
Moreover, the conditions inside the body of every patient
are changing as a result of accumulated drug effect i.e. intra-
patient variability. The parameters of the patient model need
to be updated regularly.
The pain sensor is supposed to measure a pain signal in
an unconscious patient. However, there is no reliable way to
validate the pain sensor once it is developed as the patient
is the only one who can feel the pain but he is not able to
indicate it anymore because he is unconscious.
Even if you can objectively proof that the pain sensor
picks up a pain signal in one patient, it is not certain that the
sensor will have the same result in a different patient as the
pain threshold for one person can be completely different for
each person. This is the result of the inter- and intra-patient
variabilities that pose an extra challenge on the development
of the pain sensor.
Another major challenge in this research direction is the
fact that a combination of drugs is administered to the
patient. Therefore, it is difficult to completely separate and
validate the effect of the analgesic drug.
V. CONCLUSIONS
This paper proposes an early dawn pain sensor to measure
analgesia level in unconscious patients. The proposed sensor
can be used in combination with a model-based predictive
control strategy to control the level of anesthesia in an
unconscious patient. To model the diffusion process in the
human body a fractional-order impedance model is applied.
The coinciding challenges in this research direction include
identification of the patient model, validation of the pain
sensor and validation of the effect of the analgesic drug.
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